Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

Clinical trial NCT00977977 · RECRUITING

Trial details

NCT number: NCT00977977
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Nephrotic Syndrome Proteinuria Autoimmune Disease Glomerular Disease Membranous Glomerulonephritis

Start date: 2010-12-22
Primary completion: 2027-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.